Sign Up Today and Learn More About SURGE Therapeutics Stock
Invest in or calculate the value of your shares in SURGE Therapeutics or other pre-IPO companies through EquityZen's platform.
SURGE Therapeutics Stock (SUGT)
SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.
About SURGE Therapeutics Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
SURGE Therapeutics Press Mentions
Stay in the know about the latest news on SURGE Therapeutics
SURGE Therapeutics Inks $26M Series A
vcnewsdaily • Oct 18, 2022
Biotech Startup Surge Therapeutics Gathers $26 Million for Cancer Treatment
wsj • Oct 18, 2022
SURGE Therapeutics Management
Leadership team at SURGE Therapeutics
Board Member
Kouki Harasaki
CEO and Founder
Michael Goldberg
Join now and verify your accreditation status to gain access to:
- SURGE Therapeutics current valuation
- SURGE Therapeutics stock price
- Available deals in SURGE Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading SURGE Therapeutics Stock
How to invest in SURGE Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like SURGE Therapeutics through EquityZen funds. These investments are made available by existing SURGE Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell SURGE Therapeutics stock?
Shareholders can sell their SURGE Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
